Medpor Nose Job Implants Linked to Infections, Complications: Study

The findings of a new study seem to indicate an unusually high rate of infections and complications linked to patients who have received Medpor nose job implants.  

Research published online August 27 by the Archives of Facial Plastic Surgery identified an increased rate of postoperative infection for nose job surgeries that used Medpor implants.

The study evaluated 662 rhinoplasty surgeries, some using common skin graft and others involving the use of alloplasty implants. The procedures were performed by three faculty surgeons at the Oregon Health and Sciences University in Portland from 1999 to 2008.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The study found an incidence of postoperative infection of 2.8 percent for all 662 of the procedures. Infections occurred in roughly 20 percent of patients that underwent procedures in which Medpor implants were used.

Of the 662 surgeries, Medpor or Gore-Tex implants were used in 151 of the procedures. In the cases where only Gore-Tex was used, another common implant made from expanded polytetrafluoroethylene (ePTFE) and manufactured by W.L. Gore & Associates, the infection rate was only 5.3 percent.

In nearly all the procedures where either implant was used, the implant began to protrude through the nose. In procedures where surgeons grafted tissues from the patients, there were no complications.

Rhinoplasty surgery, more commonly referred to as a nose job, is surgery on the nose done to change its appearance, and is sometimes completed with a common plastic implant.

Medpor nose implants, manufactured by Stryker Corp. and acquired from Porex Technologies in 2010, is a product made from porous high-density polyethylene (pHDPE).

Implants are often used in rhinoplasty surgery when a patient’s tissue or cartilage is unavailable from the nose, ear or ribs to graft and use for the surgery. Surgeons often prefer to graft a patients cartilage; however that takes more time than using a plastic implant.

Andrew Winkler, MD, co-author of the study and plastic surgeon at the University of Colorado in Denver, noted in the study, “Caution is strongly recommended when considering the use of pHDPE in rhinoplasty.”

Medpor and Gore-Tex are used for differing reasons. According to Winkler, one is soft and the other is stiff, so they are not interchangeable.

An infection resulting from a nose job surgery will often lead to another surgery, in order to remove the implant. Most often, antibiotics alone will not alleviate the infection.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.